332 related articles for article (PubMed ID: 23487264)
1. Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma.
Ding J; Huang S; Wang Y; Tian Q; Zha R; Shi H; Wang Q; Ge C; Chen T; Zhao Y; Liang L; Li J; He X
Hepatology; 2013 Aug; 58(2):654-66. PubMed ID: 23487264
[TBL] [Abstract][Full Text] [Related]
2. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
Zhao L; Zhang Y
Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
[TBL] [Abstract][Full Text] [Related]
3. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α.
Bao C; Li Y; Huan L; Zhang Y; Zhao F; Wang Q; Liang L; Ding J; Liu L; Chen T; Li J; Yao M; Huang S; He X
Sci Signal; 2015 Jul; 8(387):ra75. PubMed ID: 26221053
[TBL] [Abstract][Full Text] [Related]
4. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Fang Y; Xue JL; Shen Q; Chen J; Tian L
Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835
[TBL] [Abstract][Full Text] [Related]
6. MiR-16 inhibits hepatocellular carcinoma progression by targeting FEAT through NF-κB signaling pathway.
Su XF; Li N; Meng FL; Chu YL; Li T; Gao XZ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10274-10282. PubMed ID: 31841182
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM
Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways.
Zhang L; Yang L; Liu X; Chen W; Chang L; Chen L; Loera S; Chu P; Huang WC; Liu YR; Yen Y
Hepatology; 2013 May; 57(5):1919-30. PubMed ID: 23175432
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways.
Scisciani C; Vossio S; Guerrieri F; Schinzari V; De Iaco R; D'Onorio de Meo P; Cervello M; Montalto G; Pollicino T; Raimondo G; Levrero M; Pediconi N
J Hepatol; 2012 Apr; 56(4):855-61. PubMed ID: 22178270
[TBL] [Abstract][Full Text] [Related]
11. Perturbation of MicroRNA-370/Lin-28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma.
Xu WP; Yi M; Li QQ; Zhou WP; Cong WM; Yang Y; Ning BF; Yin C; Huang ZW; Wang J; Qian H; Jiang CF; Chen YX; Xia CY; Wang HY; Zhang X; Xie WF
Hepatology; 2013 Dec; 58(6):1977-91. PubMed ID: 23728999
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
14. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway.
Dai T; Zhang D; Cai M; Wang C; Wu Z; Ying Z; Wu J; Li M; Xie D; Li J; Song L
J Pathol; 2015 Feb; 235(3):490-501. PubMed ID: 25385148
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42.
Wang R; Zhao N; Li S; Fang JH; Chen MX; Yang J; Jia WH; Yuan Y; Zhuang SM
Hepatology; 2013 Aug; 58(2):642-53. PubMed ID: 23468064
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-127-5p targets the biliverdin reductase B/nuclear factor-κB pathway to suppress cell growth in hepatocellular carcinoma cells.
Huan L; Bao C; Chen D; Li Y; Lian J; Ding J; Huang S; Liang L; He X
Cancer Sci; 2016 Mar; 107(3):258-66. PubMed ID: 26708147
[TBL] [Abstract][Full Text] [Related]
19. miR-183 potentially inhibits NF-κB1 expression by directly targeting its 3'-untranslated region.
Sha F; Wu S; Zhang H; Guo X
Acta Biochim Biophys Sin (Shanghai); 2014 Nov; 46(11):991-6. PubMed ID: 25274328
[TBL] [Abstract][Full Text] [Related]
20. Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling.
Wen J; Huang Z; Wei Y; Xue L; Wang Y; Liao J; Liang J; Chen X; Chu L; Zhang B
Cell Mol Biol Lett; 2022 Sep; 27(1):79. PubMed ID: 36138344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
